Mizzou Students Throw Support Behind Medical Pot Initiative: 'It's Just a Plant'
*By Carlo Versano*
On Tuesday, Missouri could become the 32nd state in the U.S. to legalize medical marijuana.
On the ballot are three proposals on the issue ー regarding regulation, taxation, and the distribution of tax revenues. The amendments are byzantine and confusing, but if one passes, medical marijuana will become the law of the land in the "Show-Me" State.
Cannabis legalization has garnered more public support in recent years, and medical pot is often thought to be the gateway to fuller legalization. While the Missouri medical community is [split](https://kcmedicine.org/survey-results-physician-attitudes-medical-marijuana/) on the drug's medicinal value, much of the student body at the University of Missouri has a pro-legalization stance.
CheddarU went to Mizzou's campus to hear what students had to say ahead of the vote.
"I just can't see any good reason not to have it medicinally available here," said In'lana Henderson, VP of Students for Sensible Drug Policy at Mizzou.
"People think that it's very taboo here," she added.
That possibility that Missouri, a reliably red state in the country's heartland, could pass a progressive drug law, gives some students hope that the end result could galvanize public support for cannabis legalization.
"I think that if we can legalize it, it will help other states do that, too," freshman Payton Nichols-Pittman said.
Or, as senior Meg Rogers put it: "It's just something that we don't need to make people feel bad for."
She added: "It's just a plant."
Aya Kantorovich, Co-CEO of August Digital, breaks down Bitcoin’s surge, crypto ETFs, institutional investment trends, and the future of safer crypto access.
Most members of the Federal Reserve’s interest-rate setting committee supported further reductions to its key interest rate this year, minutes from last month’s meeting showed.
Sinead O’Sullivan breaks down Taylor Swift’s genius marketing for The Life of a Showgirl, which just set the record for most albums sold in a single week.
Markets are emerging from a turbulent Q3. Horizon’s Mike Dickson shares insights on interest rates, small caps, and where investors should look in Q4 and beyond
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
Former Cisco Systems CEO John Chambers learned all about technology’s volatile highs and lows as a veteran of the internet’s early boom days during the late 1990s and the ensuing meltdown that followed the mania. And now he is seeing potential signs of the cycle repeating with another transformative technology in artificial intelligence. Chambers is trying take some of the lessons he learned while riding a wave that turned Cisco into the world's most valuable company in 2000 before a crash hammered its stock price and apply them as an investor in AI startups. He recently discussed AI's promise and perils during an interview with The Associated Press.
Grove Collaborative’s CEO shares how the company is reinventing everyday goods with sustainability at the core and working toward a plastic-free future.
